SLC2A1 and cancer: A recent paper showed a relationship between miRNA-218 and the function of GLUT (glucose transporter)-1 across tumoral bladder cells: the overexpression of miRNA-218 could have contributed to decreased sensitivity of bladder cancer cells to cisplatin by inhibiting GLUT-1 expression, a key rate-limiting factor in the transport of glucose in these cancer cells (Li et al., 2017).